![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 49829](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-56.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 49831](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-57.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51209](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-cbrn-1.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 49833](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-58.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 49835](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-59.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51211](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-space-big-science-1.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51200](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-optronics.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51204](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-optomechanical.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51202](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-photonics.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51212](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-application-center.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51214](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-distributor-map.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51216](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-register-1.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51218](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-media.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 51220](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-faq.svg)
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 69984](https://www.bertin-technologies.com/wp-content/uploads/2024/06/about-us-2.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 76107](https://www.bertin-technologies.com/wp-content/uploads/2024/12/values.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 69981](https://www.bertin-technologies.com/wp-content/uploads/2024/06/governance.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 69990](https://www.bertin-technologies.com/wp-content/uploads/2024/06/business-units.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 69987](https://www.bertin-technologies.com/wp-content/uploads/2024/06/subsidiaries.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 69997](https://www.bertin-technologies.com/wp-content/uploads/2024/06/location.png){kind=small}
![[PRECELLYS] Viable herpes virus isolation from infected mouse ganglia with Minilys Bertin Technologies 70000](https://www.bertin-technologies.com/wp-content/uploads/2024/06/certifications.png){kind=small}
Context
The research focus of our laboratory is on human herpes virus pathogenesis and the development of new treatments and vaccines. We often need to test herpes simplex viruses (HSV) and their mutants in a mouse model to study the function of viral genes, evaluate antiviral therapies, and assess the efficacy of vaccine candidates. The titer of infectious HSV in the sensory nerve ganglion innervating the inoculation site is a crucial measurement for these studies.
